Annals of Emergency Medicine
Volume 53, Issue 3 , Pages 329-338, March 2009

Clevidipine, an Intravenous Dihydropyridine Calcium Channel Blocker, Is Safe and Effective for the Treatment of Patients With Acute Severe Hypertension

Presented as a poster at the American College of Emergency Physicians 2007 Scientific Assembly, October 2007, Seattle, WA.

  • Charles V. Pollack, MD, MA

      Affiliations

    • Department of Emergency Medicine, Pennsylvania Hospital, University of Pennsylvania, Philadelphia, PA
    • Corresponding Author InformationAddress for correspondence: Charles V. Pollack, MA, MD, Department of Emergency Medicine, Pennsylvania Hospital, 800 Spruce Street, 2 Pine East, Philadelphia, PA 19107; 215-829-7549, fax 610-687-0137
    • ,
  • Joseph Varon, MD

      Affiliations

    • The University of Texas Health Science Center at Houston, The University of Texas Medical Branch at Galveston, St. Luke's Episcopal Hospital/Texas Heart Institute, Houston, TX
    • ,
  • Norman A. Garrison, MD

      Affiliations

    • Jackson Hospital, Montgomery, AL
    • ,
  • Ramin Ebrahimi, MD

      Affiliations

    • University of California Los Angeles and VA Greater Los Angeles Healthcare Center, Los Angeles, CA
    • ,
  • Lala Dunbar, MD

      Affiliations

    • Louisiana State University Health Science Center, New Orleans, LA
    • ,
  • W. Frank Peacock IV, MD

      Affiliations

    • The Cleveland Clinic, Department of Emergency Medicine, Cleveland, OH

Received 11 January 2008; received in revised form 5 March 2008 and 11 March 2008; accepted 7 April 2008. published online 06 June 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supervising editor: Rita K. Cydulka, MD, MS

 Author contributions: All authors contributed to the development of the study protocol, enrolled patients, and participated in data analysis and drafting of the article. CP and FP take responsibility for the paper as a whole.

 Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article, that might create any potential conflict of interest. See the Manuscript Submission Agreement in this issue for examples of specific conflicts covered by this statement. Funding for this study was provided by The Medicines Company, Parsippany, NJ. Drs. Pollack, Varon, and Peacock have served as consultants for The Medicines Company.

 Publication dates: Available online June 5, 2008.

 Reprints not available from the authors.

PII: S0196-0644(08)00728-2

doi:10.1016/j.annemergmed.2008.04.025

Annals of Emergency Medicine
Volume 53, Issue 3 , Pages 329-338, March 2009

Article Tools

* Image Usage & Resolution